3 October 2024 - Meet & Greet on Tour, startup edition
We are pleased to announce a new career event for PhD students. Last year we visited three interesting companies in the field of medicine and the biotech industry, to explore possible career paths for you as early career researchers. This year, we invite you to join us if you are interested in learning how to start your own business and to hear what that is like.
When: Thursday October 3, 2024
Where: starting at Zernike Campus
What: please see the general programme below, as well as information about the participating startup companies.
Registration: use the button below to register for this event!
Programme outline (still slightly under construction)
- 09:45-10:00 walk-in with coffee and tea
- 10:00-11.00 Plenary meeting @ Zernike consisting of a presentation by the department of Knowledge Utilization and Entrepreneurship and QDI Systems
- 11:00-12:00 First company visit
- 12:00 - 12:50 Lunch @ Zernike - provided by us
- 13:00 - 14:00 Second company visit
- 14:00 - 15:00 Third company visit
- short travel by bike
- 15:20-16:20 Fourth company visit
- 16:20 - 17:00 Closing drinks
The startups
Sencilia BV - safer infusion therapy for improved patient outcomes
Sencilia, an early-stage MedTech startup, is a spin-off from the Bioinspired MEMS and Biomedical Devices (BMBD) group at the University of Groningen. Dr. Amar M. Kamat (former postdoc in BMBD and currently the CEO of Sencilia) and Prof. Ajay G.P. Kottapalli (Associate Professor and Chair of the BMBD group) founded Sencilia in Sep 2021 in order to utilize and valorize the extensive knowhow in sensor technology and nanofabrication generated within the BMBD group over many years.
Sencilia aims to enhance the safety of IV infusion therapy, and harbors the vision of becoming the standard of care in IV drug administration by 2030.
Portal Biotech BV - opening the door to universal proteomics
To understand proteins and metabolites is to understand ourselves: how we work, our health, how we respond to treatments and interventions.
Portal’s mission is to provide scientists and clinicians with the tools they need to kick-start the proteomics revolution, enable new discoveries in the fields of health and biology, and reduce the time taken to bring new drugs and treatments to clinical trial.
Gecco Biotech B.V. - unique novel enzymes and cofactors
Gecco Biotech is committed to devising and developing sustainable enzymatic solutions for a wide range of fields, including chemistry, pharma and F&F. Their services range from enzyme discovery & engineering to downstream processing. Using state of the art expertise, they develop novel enzymes, or improve variants, by improving target processes through engineering of enzymes for increased stability, specificity or activity.
HQ Graphene - high quality 2D crystals
HQ Graphene is a manufacturer of high quality 2D single crystals, selling directly to over 190 universities, research institutes and companies worldwide. Our customers are scientists demanding high purity and high quality crystals for scientific research.
Our scientific staff has the expertise in the production and characterization of large size and high purity single crystals. The crystals are characterized with X-ray diffraction (single crystal XRD and powder XRD), Energy-dispersive X-ray spectroscopy (EDX), Raman and additionally with Hall measurements.
| Last modified: | 11 July 2024 11.47 a.m. |